T. Bijma

Protein interaction verification and functional annotation by integrated analysis of genome-scale data.

P. Kemmeren, F. Holstege, A. Brazma, 2002, Molecular cell.

A high resolution protein interaction map of the yeast Mediator complex.

F. Holstege, N. V. van Berkum, T. Bijma, 2004, Nucleic acids research.

The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells

T. Bijma, W. Helfrich, Douwe F Samplonius, 2007, Leukemia.

A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability

T. Bijma, G. Fey, G. Huls, 2009, Leukemia.

Increased miR-142-3p Expression Might Explain Reduced Regulatory T Cell Function in Granulomatosis With Polyangiitis

T. Bijma, A. van den Berg, B. Kroesen, 2019, Front. Immunol..

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells

T. Bijma, W. Helfrich, E. Bremer, 2008, Journal of Molecular Medicine.

Predicting gene function through systematic analysis and quality assessment of high-throughput data

Frank Holstege, Thessa T. J. P. Kockelkorn, Patrick Kemmeren, 2005, Bioinform..

Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study

T. Bijma, P. Heeringa, W. Abdulahad, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Genome-wide location of the coactivator mediator: Binding without activation and transient Cdk8 interaction on DNA.

P. Lijnzaad, M. G. Koerkamp, F. Holstege, 2006, Molecular cell.

Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.

T. Bijma, T. Kuijpers, L. Bergamaschi, 2023, Journal of autoimmunity.